This inventor holds 8 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hanno, JP (2014 - 2016)
- Tsukuba, JP (2017 - 2021)
Company Filing History:
Years Active: 2014-2026
Title: **The Innovative Contributions of Takao Uno**
Introduction
Takao Uno is a prominent inventor based in Tsukuba, Japan, known for his significant contributions to pharmaceutical chemistry. He holds a total of seven patents that showcase his dedication to advancing medical science and improving drug formulations.
Latest Patents
Uno's latest patents include innovative crystals of an azabicyclic compound, specifically 3-ethyl-4-{3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl}benzamide. These crystals are notable for their stability and excellent oral absorbability, which are critical attributes in pharmaceutical applications. The Form II crystals demonstrate an X-ray powder diffraction spectrum with at least three characteristic peaks at specific angles ranging from 7.7° to 27.4°, marking a crucial advancement in the formulation of effective medication.
Career Highlights
Uno's career is marked by his tenure at Taiho Pharmaceutical Company Limited, where he has played a vital role in driving research and innovation forward. His work at the company reflects a commitment to excellence in pharmaceutical development, contributing positively to the healthcare sector.
Collaborations
Throughout his career, Takao Uno has collaborated with esteemed colleagues, including Tadashi Shimamura and Makoto Kitade. These collaborations have further enriched his research, leading to groundbreaking outcomes and advancements in drug discovery.
Conclusion
In summary, Takao Uno's inventive spirit and solid research within the pharmaceutical field are evidenced through his patents and collaborations. His innovations are set to impact the delivery and effectiveness of crucial medications, solidifying his position as a notable inventor in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
